We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Companies Seek Trademarks At Early Stage, Survey Finds

Law360 (February 19, 2004, 12:00 AM EST) -- Drug companies are developing trademarks for new products at an early stage in an effort to entrench a brand in the minds of physicians, a new survey has found.

The overwhelming majority of the companies surveyed develops the generic and trademark names--92% and 84% respectively--by or during Phase II of clinical trials, according to a new benchmark study by consulting firm Best Practices, LLC.

As many as 40% of companies use the trademark before using the generic name, reflecting a growing trend to entrench the trademark...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.